Cantharidin Patent Expiration

Cantharidin is Used for treating molluscum contagiosum skin lesions in patients 2 years and older. It was first introduced by Verrica Pharmaceuticals Inc in its drug Ycanth on Jul 21, 2023.

Cantharidin Patents

Given below is the list of patents protecting Cantharidin, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Ycanth US11052064 Compositions, methods and systems for the treatment of cutaneous disorders May 28, 2035 Verrica Pharms
Ycanth US11147790 Treatment of cutaneous disorders Aug 22, 2038 Verrica Pharms

Coming Soon

Patent Strength Analyzer

Will this be useful for you?


Thank you for your response 🥳